Povero, M. et al. 2014. Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey. Farmeconomia. Health economics and therapeutic pathways. 15, 2 (Jun. 2014), 39–44. DOI:https://doi.org/10.7175/fe.v15i2.924.